For the year ending 2025-12-31, KAPA has $6,540K in assets. $4,491K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 4,491 | |||
| Vendor advances, gross | 3,271 | |||
| Less accumulated amortization | 2,426 | |||
| Vendor advances, net | 845 | |||
| Prepaid expenses and other current assets | 51 | |||
| Total current assets | 5,387 | |||
| Deferred offering costs | 1,091 | |||
| Intangible assets, net | 62 | |||
| Total other assets | 1,153 | |||
| Total assets | 6,540 | |||
| Accounts payable and accrued expenses | 199 | |||
| Total current liabilities | 199 | |||
| Common stock, par value 0.001, 100,000,000 shares authorized 20,821,353 and 13,736,597 shares issued and outstanding, respectively | 21 | |||
| Additional paid-in capital | 20,582 | |||
| Accumulated deficit | -14,262 | |||
| Total shareholders equity | 6,341 | |||
| Total liabilities and shareholders equity | 6,540 | |||
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)